Isomorphic Labs vs Stripe
Side-by-side comparison of AI visibility scores, market position, and capabilities
Alphabet/DeepMind drug discovery spinoff raised $600M from Thrive Capital; Drug Design Engine doubled AlphaFold3 accuracy for molecular design; partnering with major pharma; preparing first clinical trials from AI-directed drug pipeline across multiple therapeutic areas.
About
Isomorphic Labs is an Alphabet company spun out of Google DeepMind to apply AI to the full drug discovery pipeline, from target identification through molecular design and clinical candidate selection. Founded in 2021 under CEO Demis Hassabis's vision of using AI to accelerate medicine, Isomorphic operates with the scientific resources and computational infrastructure of DeepMind while functioning as a standalone drug discovery organization. The company's founding mission is to use AI not merely as a tool to assist drug hunters, but as the primary engine of drug design — replacing the slow, expensive, and largely empirical process of traditional medicinal chemistry with AI-directed molecular engineering.\n\nIsomorphic's core platform is the Drug Design Engine, a proprietary AI system built on top of AlphaFold architecture. The Drug Design Engine has achieved landmark performance results, reportedly doubling the accuracy of AlphaFold3 at predicting how small molecules bind to their protein targets — the fundamental problem in structure-based drug design. This capability enables Isomorphic to computationally design molecules predicted to bind their targets with far greater precision than conventional methods, potentially eliminating many of the expensive iterative cycles that make drug development so slow. The company has also established major pharma partnerships with Eli Lilly and Novartis to co-develop drug candidates across multiple therapeutic areas.\n\nIsomorphic raised $600M from Thrive Capital in 2024–2025, bringing substantial private capital alongside its Alphabet backing to accelerate pipeline development. As of 2026, the company is preparing for its first clinical trials — a critical milestone that will test whether its computational drug design predictions translate into human efficacy. With AlphaFold-derived technology at its core, partnerships with two of the world's largest pharmaceutical companies, and over half a billion in funding, Isomorphic Labs represents the most credentialed and well-resourced pure-play AI drug discovery company in existence.
Global payments infrastructure founded by Patrick and John Collison (YC W10); $1.4T payments volume in 2024; $18B+ revenue; $106.7B valuation as of Sept 2025; powers everything from startups to Fortune 500 companies with developer-first API design.
About
Stripe is a global payments infrastructure company founded in 2010 by Irish brothers Patrick and John Collison, headquartered in San Francisco, California and Dublin, Ireland. Stripe was born from the insight that accepting payments online was unnecessarily complex for developers, and that a well-designed API could unlock an entire generation of internet businesses. The company went through Y Combinator's Winter 2010 batch and grew to become the defining payments infrastructure layer of the modern internet economy, processing payments for businesses in virtually every industry worldwide.\n\nStripe's platform provides payment processing, fraud prevention via Stripe Radar, subscription billing, revenue recognition, banking-as-a-service through Stripe Treasury, corporate card issuance, identity verification, and tax compliance tools. It serves a spectrum from early-stage startups to publicly traded enterprises including Amazon, Google, Salesforce, and Shopify. Stripe's developer-first philosophy — comprehensive documentation, SDKs in every major language, and a sandbox testing environment — created an ecosystem of millions of businesses built entirely on its infrastructure.\n\nStripe processed $1.4 trillion in total payment volume in 2024 and generates over $18 billion in annual revenue, with a valuation of $106.7 billion as of September 2025. The company has remained private longer than most comparably sized technology companies, giving it flexibility to invest in long-term product expansion. An April 2024 partnership with Apple Pay extended Stripe's reach further into mobile and in-store commerce. Stripe competes with Adyen, Braintree (PayPal), and Square, but its developer ecosystem depth and global infrastructure make it the default payments platform for a generation of technology companies.
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.